Article Type
Changed
Wed, 09/12/2018 - 08:39
Display Headline
Safety of statins: Effects on muscle and the liver
Article PDF
Author and Disclosure Information

Abu R. Vasudevan, MBBS, MD, MRCP
Clinical Instructor, Division of Endocrinology and Metabolism, Center for Cardiovascular Disease Prevention, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Yasmin S. Hamirani, MBBS
Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Peter H. Jones, MD
Associate Professor, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, 6565 Fannin, Suite B160, Mail stop A601, Houston, TX 77030; e-mail jones@bcm.tmc.edu

Dr. Jones has indicated that he has received grant or research support from the Abbott, AstraZeneca, KOS, and Pfizer corporations.

Issue
Cleveland Clinic Journal of Medicine - 72(11)
Publications
Topics
Page Number
990-993, 996-1001
Sections
Author and Disclosure Information

Abu R. Vasudevan, MBBS, MD, MRCP
Clinical Instructor, Division of Endocrinology and Metabolism, Center for Cardiovascular Disease Prevention, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Yasmin S. Hamirani, MBBS
Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Peter H. Jones, MD
Associate Professor, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, 6565 Fannin, Suite B160, Mail stop A601, Houston, TX 77030; e-mail jones@bcm.tmc.edu

Dr. Jones has indicated that he has received grant or research support from the Abbott, AstraZeneca, KOS, and Pfizer corporations.

Author and Disclosure Information

Abu R. Vasudevan, MBBS, MD, MRCP
Clinical Instructor, Division of Endocrinology and Metabolism, Center for Cardiovascular Disease Prevention, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Yasmin S. Hamirani, MBBS
Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Peter H. Jones, MD
Associate Professor, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, 6565 Fannin, Suite B160, Mail stop A601, Houston, TX 77030; e-mail jones@bcm.tmc.edu

Dr. Jones has indicated that he has received grant or research support from the Abbott, AstraZeneca, KOS, and Pfizer corporations.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(11)
Issue
Cleveland Clinic Journal of Medicine - 72(11)
Page Number
990-993, 996-1001
Page Number
990-993, 996-1001
Publications
Publications
Topics
Article Type
Display Headline
Safety of statins: Effects on muscle and the liver
Display Headline
Safety of statins: Effects on muscle and the liver
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media